Defect-Rich BiO₂₋<sub>x</sub>-BP Composite Nanoplatform: A Synergistic Approach for X-Ray and Near-Infrared-Enhanced Cancer Radiodynamic Therapy.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 39935071.
- Also identified by DOI 10.1002/adhm.202404815.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Cancer treatment faces significant challenges, including hypoxia within the tumor microenvironment, which limits the efficacy of conventional therapies. This study introduces a multifunctional nanoplatform comprising defect-rich BiO₂₋<sub>x</sub> and black phosphorus (BP) nanosheets to address this issue. BiO₂₋<sub>x</sub> effectively catalyzes the decomposition of tumor-overexpressed H₂O₂ into oxygen, mitigating hypoxia. Its high atomic number enhances X-ray absorption, increasing local radiation doses. When combined with BP, BiO₂₋<sub>x</sub> forms a heterojunction that produces secondary electrons, generating reactive oxygen species (ROS) like ·OH under X-ray irradiation. Additionally, under 808 nm near-infrared (NIR) light, the platform exhibits strong photothermal effects, further enhancing cancer cell apoptosis. In vitro and in vivo experiments demonstrate the nanoplatform's remarkable ability to synergize radiotherapy, photothermal therapy, and radiodynamic therapy, resulting in significant tumor suppression without adverse effects on major organs. This innovative approach highlights the potential of BiO₂₋<sub>x</sub>-BP composites for addressing hypoxia and achieving multimodal cancer therapy.
Medical subject headings
- Phosphorus
- Neoplasms